EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deletion of the Epidermal Protease KLK5 Aggravates the Symptoms of Congenital Ichthyosis CDSN-nEDD

Eleni Zingkou iD, Marie Reynier, Georgios Pampalakis iD, Guy Serre, Nathalie Jonca iD, Georgia Sotiropoulou

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Eleni Zingkou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Health Sciences, University of Patras, Rion, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Kallikreins, Epidermis, Ichthyosis, Serine Peptidase Inhibitor Kazal-Type 5. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERANET-E-RARE-3, ERA-NET/E-Rare-3: Joint Translational Call.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital ichthyoses, now grouped under the acronym EDD (Epidermal Differentiation Disorders), include nonsyndromic forms (nEDD) that may be caused by loss-of-function mutations in the CDSN gene encoding corneodesmosin (CDSN-nEDD, formerly Peeling skin syndrome type 1). It is characterized by skin peeling, inflammation, itching and food allergies, while no specific therapy is currently available. High levels of KLK5, the serine protease that initiates the desquamation cascade, are found in the epidermis of CDSN-nEDD patients. Thus, we hypothesized that KLK5 inhibition would alleviate the symptoms of CDSN-nEDD and could serve as a new pharmacological target. A human epidermal equivalent (HEE) model for CDSN-nEDD was developed using shRNA-mediated CDSN knockdown. This model was characterized and used to assess the role of KLK5 knockdown on CDSN-nEDD. Also, Klk5−/− mice were crossed with Cdsnepi−/− mice, the murine model of CDSN-nEDD, to examine in vivo the effect(s) of Klk5 deletion in CDSN-nEDD. Both models recapitulated the CDSN-nEDD desquamating phenotype. Elimination of KLK5 aggravated the CDSN-nEDD phenotype. Epidermal proteolysis was surprisingly elevated, while severe ultrastructural (corneo)desmosomal alterations increased epidermal barrier permeability and stratum corneum detachment was manifested. Based on these results, we concluded that targeting epidermal proteolysis with KLK5 ablation cannot compensate for the loss of corneodesmosin and rescue over-desquamation of the CDSN-nEDD. Possibly, in the absence of KLK5, other proteases take over which increases the severity of over-desquamation in CDSN-nEDD. The translational outcome is that over-desquamation may not always be rescued by eliminating epidermal proteolysis, but fine protease modulation is more likely required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KallikreinsEpidermisIchthyosisSerine Peptidase Inhibitor Kazal-Type 5Membrane ProteinsAnimalsHumansMiceDisease Models, AnimalMice, KnockoutGene DeletionIntercellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

CDSN-nEDD (Peeling skin syndrome type 1)Epidermal Differentiation Disorders (EDD)corneodesmosin (CDSN)epidermal lipidsepidermal proteolysishuman epidermal equivalent (HEE)kallikrein 5 (KLK5)mouse models

Substanzen

KallikreinsSerine Peptidase Inhibitor Kazal-Type 5Klk5 protein, mouseKLK5 protein, humanCDSN protein, humanMembrane ProteinsIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Pharmacy, School of Health Sciences, University of Patras, Rion, 26504 Patras, Greece.
  • Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), CNRS, Toulouse University, Inserm, 31024 Toulouse, France.
  • Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Department of Cell Biology and Cytology, Federative Institute of Biology, Purpan University Hospital, 31300 Toulouse, France.

ORCID-Profile: Eleni Zingkou, Georgios Pampalakis, Nathalie Jonca

Förderung

  • ERANET-E-RARE-3
  • ERA-NET/E-Rare-3: Joint Translational Call

Zitieren

APA

Zingkou, E., Reynier, M., Pampalakis, G., Serre, G., Jonca, N., & Sotiropoulou, G. (2025). Deletion of the Epidermal Protease KLK5 Aggravates the Symptoms of Congenital Ichthyosis CDSN-nEDD. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178605

Vancouver

Zingkou E, Reynier M, Pampalakis G, Serre G, Jonca N, Sotiropoulou G. Deletion of the Epidermal Protease KLK5 Aggravates the Symptoms of Congenital Ichthyosis CDSN-nEDD. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178605

BibTeX
@article{Zingkou2025,
  author = {Zingkou, Eleni and Reynier, Marie and Pampalakis, Georgios and Serre, Guy and Jonca, Nathalie and Sotiropoulou, Georgia},
  title = {Deletion of the Epidermal Protease KLK5 Aggravates the Symptoms of Congenital Ichthyosis CDSN-nEDD},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178605}
}
Kostenlos starten →